X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-13 | INSM | Smith Michael Alexander | GC | S - Sale+OE | $74.35 | -27,871 | 67,856 | -29% | -$2,072,223 | |||||
| DM | 2024-09-12 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale+OE | $74.91 | -41,040 | 106,134 | -28% | -$3,074,177 | |||||
| D | 2024-09-10 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale+OE | $71.50 | -37,575 | 100,100 | -27% | -$2,686,615 | |||||
| D | 2024-09-06 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale+OE | $71.23 | -149,002 | 106,134 | -58% | -$10,613,387 | |||||
| D | 2024-08-12 | INSM | Smith Michael Alexander | GC | S - Sale+OE | $72.96 | -88,070 | 88,727 | -50% | -$6,425,466 | |||||
2024-08-12 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale | $72.49 | -9,469 | 100,100 | -9% | -$686,408 | ||||||
| D | 2024-06-10 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale+OE | $60.00 | -21,195 | 106,134 | -17% | -$1,271,700 | |||||
| D | 2024-06-03 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale+OE | $55.33 | -55,000 | 108,760 | -34% | -$3,043,150 | |||||
| D | 2024-05-28 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale+OE | $49.79 | -7,852 | 121,657 | -6% | -$390,918 | |||||
| D | 2024-05-28 | INSM | Smith Michael Alexander | GC | S - Sale+OE | $49.53 | -44,722 | 88,828 | -33% | -$2,215,081 | |||||
| D | 2024-05-28 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale+OE | $49.53 | -27,500 | 108,760 | -20% | -$1,362,075 | |||||
| DM | 2024-05-28 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale+OE | $50.53 | -125,001 | 106,134 | -54% | -$6,316,579 | |||||
| DM | 2024-05-28 | INSM | Bonstein Sara | CFO | S - Sale+OE | $50.00 | -241,288 | 117,481 | -67% | -$12,064,607 | |||||
2024-05-17 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $25.09 | -4,642 | 106,134 | -4% | -$116,468 | ||||||
2024-05-17 | INSM | Adsett Roger | COO | S - Sale | $25.09 | -5,945 | 149,275 | -4% | -$149,160 | ||||||
| D | 2024-05-14 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale+OE | $25.47 | -5,088 | 123,259 | -4% | -$129,591 | |||||
| D | 2024-05-14 | INSM | Smith Michael Alexander | GC | S - Sale+OE | $25.40 | -5,093 | 94,579 | -5% | -$129,362 | |||||
| D | 2024-05-14 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale+OE | $25.53 | -6,508 | 108,760 | -6% | -$166,149 | |||||
| D | 2024-05-14 | INSM | Lewis William | Chair, CEO | S - Sale+OE | $25.52 | -22,198 | 668,549 | -3% | -$566,493 | |||||
| D | 2024-05-14 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale+OE | $25.47 | -10,640 | 110,776 | -9% | -$271,001 | |||||
| D | 2024-05-14 | INSM | Bonstein Sara | CFO | S - Sale+OE | $25.32 | -11,088 | 117,481 | -9% | -$280,748 | |||||
| D | 2024-05-14 | INSM | Adsett Roger | COO | S - Sale+OE | $25.50 | -7,857 | 155,220 | -5% | -$200,354 | |||||
2024-01-12 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $28.63 | -4,667 | 106,898 | -4% | -$133,616 | ||||||
2024-01-12 | INSM | Adsett Roger | COO | S - Sale | $28.63 | -5,251 | 148,559 | -3% | -$150,336 | ||||||
2024-01-09 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale | $28.78 | -1,861 | 113,829 | -2% | -$53,560 | ||||||
2024-01-09 | INSM | Smith Michael Alexander | GC, SVP | S - Sale | $28.76 | -2,373 | 86,364 | -3% | -$68,247 | ||||||
| D | 2024-01-09 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale+OE | $28.85 | -3,668 | 101,984 | -3% | -$105,831 | |||||
| M | 2024-01-09 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $28.99 | -5,960 | 111,565 | -5% | -$172,763 | |||||
2024-01-09 | INSM | Bonstein Sara | CFO | S - Sale | $29.18 | -4,497 | 114,051 | -4% | -$131,222 | ||||||
| M | 2024-01-09 | INSM | Adsett Roger | COO | S - Sale | $29.08 | -7,373 | 153,810 | -5% | -$214,423 | |||||
| DM | 2024-01-08 | INSM | Lewis William | Chair, CEO | S - Sale+OE | $29.32 | -55,007 | 598,075 | -8% | -$1,612,928 | |||||
| DM | 2024-01-03 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale+OE | $29.20 | -21,238 | 219,674 | -9% | -$620,089 | |||||
| D | 2024-01-05 | INSM | Smith Michael Alexander | GC, SVP | S - Sale+OE | $29.31 | -627 | 88,737 | -1% | -$18,374 | |||||
| D | 2024-01-05 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale+OE | $29.28 | -1,457 | 105,149 | -1% | -$42,661 | |||||
| D | 2024-01-05 | INSM | Lewis William | Chair, CEO | S - Sale+OE | $29.26 | -6,979 | 607,962 | -1% | -$204,195 | |||||
| D | 2024-01-05 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale+OE | $29.21 | -1,386 | 117,525 | -1% | -$40,478 | |||||
| D | 2024-01-05 | INSM | Adsett Roger | COO | S - Sale+OE | $29.21 | -3,042 | 161,183 | -2% | -$88,864 | |||||
| D | 2023-12-28 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale+OE | $32.00 | -22,288 | 94,549 | -19% | -$713,216 | |||||
| D | 2023-12-22 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale+OE | $30.00 | -28,310 | 106,038 | -21% | -$849,300 | |||||
2023-12-22 | INSM | Bonstein Sara | CFO | S - Sale | $30.00 | -13,199 | 105,241 | -11% | -$395,970 | ||||||
| D | 2023-10-27 | INSM | Lewis William | Chair, CEO | S - Sale+OE | $24.08 | -112,000 | 576,572 | -16% | -$2,696,449 | |||||
2023-07-11 | INSM | Smith Michael Alexander | GC, SVP | S - Sale | $20.18 | -740 | 77,142 | -1% | -$14,933 | ||||||
2023-06-13 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $19.27 | -8,868 | 106,038 | -8% | -$170,886 | ||||||
2023-06-13 | INSM | Adsett Roger | COO | S - Sale | $19.32 | -8,981 | 151,352 | -6% | -$173,513 | ||||||
2023-05-25 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale | $18.95 | -3,366 | 102,681 | -3% | -$63,786 | ||||||
| M | 2023-05-15 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale | $18.44 | -2,887 | 106,047 | -3% | -$53,224 | |||||
| M | 2023-05-15 | INSM | Smith Michael Alexander | GC, SVP | S - Sale | $18.77 | -3,635 | 77,082 | -5% | -$68,214 | |||||
| M | 2023-05-15 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale | $18.62 | -5,019 | 93,525 | -5% | -$93,438 | |||||
| M | 2023-05-15 | INSM | Lewis William | Chair, CEO | S - Sale | $18.58 | -16,861 | 575,269 | -3% | -$313,312 | |||||
| M | 2023-05-15 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $18.94 | -4,294 | 114,906 | -4% | -$81,328 | |||||
| M | 2023-05-15 | INSM | Bonstein Sara | CFO | S - Sale | $18.95 | -3,820 | 117,619 | -3% | -$72,390 | |||||
| M | 2023-05-15 | INSM | Adsett Roger | COO | S - Sale | $18.66 | -6,816 | 160,333 | -4% | -$127,191 | |||||
2023-05-15 | INSM | Sharoky Melvin Md | Dir | P - Purchase | $19.29 | +20,000 | 342,458 | +6% | +$385,800 | ||||||
2023-01-10 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale | $17.96 | -779 | 77,272 | -1% | -$13,991 | ||||||
2023-01-10 | INSM | Smith Michael Alexander | GC, SVP | S - Sale | $17.93 | -1,836 | 54,332 | -3% | -$32,919 | ||||||
2023-01-10 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale | $17.95 | -2,435 | 72,159 | -3% | -$43,708 | ||||||
2023-01-10 | INSM | Lewis William | Chair, CEO | S - Sale | $18.00 | -6,994 | 265,067 | -3% | -$125,892 | ||||||
2023-01-10 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $18.06 | -3,439 | 72,763 | -5% | -$62,108 | ||||||
2023-01-10 | INSM | Bonstein Sara | CFO | S - Sale | $18.12 | -2,857 | 66,031 | -4% | -$51,769 | ||||||
2023-01-10 | INSM | Adsett Roger | COO | S - Sale | $17.99 | -3,194 | 135,487 | -2% | -$57,460 | ||||||
| D | 2023-01-05 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale+OE | $19.74 | -1,160 | 78,051 | -1% | -$22,898 | |||||
| D | 2023-01-05 | INSM | Smith Michael Alexander | GC, SVP | S - Sale+OE | $19.72 | -720 | 56,168 | -1% | -$14,198 | |||||
| D | 2023-01-05 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale+OE | $19.73 | -1,448 | 74,594 | -2% | -$28,569 | |||||
| D | 2023-01-05 | INSM | Lewis William | Chair, CEO | S - Sale+OE | $19.80 | -7,008 | 272,061 | -3% | -$138,758 | |||||
| D | 2023-01-05 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale+OE | $19.73 | -1,374 | 76,202 | -2% | -$27,109 | |||||
| D | 2023-01-05 | INSM | Adsett Roger | COO | S - Sale+OE | $19.75 | -3,044 | 138,681 | -2% | -$60,119 | |||||
2022-11-22 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale | $18.84 | -7,154 | 71,613 | -9% | -$134,781 | ||||||
2022-11-22 | INSM | Adsett Roger | COO | S - Sale | $18.80 | -11,855 | 134,127 | -8% | -$222,874 | ||||||
| M | 2022-10-31 | INSM | Sharoky Melvin Md | Dir | P - Purchase | $17.59 | +30,000 | 301,552 | +11% | +$527,600 | |||||
2022-10-31 | INSM | Lee Leo | Dir | P - Purchase | $17.69 | +45,000 | 98,265 | +84% | +$796,050 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |